Silence Therapeutics Plc (NASDAQ: SLN)
$22.00
(-1.2%)
-$0.27
Price as of April 25, 2024, 11:51 a.m. ET
Silence Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Silence Therapeutics Plc Company Info
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
News & Analysis
Valuation
Earnings Transcripts
Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript
SLN earnings call for the period ending June 30, 2021.
Motley Fool Transcribing | Aug 12, 2021
Silence Therapeutics Plc (SLN) Q4 2020 Earnings Call Transcript
SLN earnings call for the period ending December 31, 2020.
Motley Fool Transcribing | May 3, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.